Description
Betmiga MR Tablets are a prescription treatment used for managing overactive bladder (OAB) symptoms in adults. These symptoms may include urgent or frequent urination, difficulty holding urine, or waking up at night to urinate (nocturia). Betmiga contains the active ingredient mirabegron, a beta-3 adrenergic receptor agonist that helps relax the bladder muscle, allowing it to hold more urine and reduce sudden urges.
Unlike older antimuscarinic treatments for OAB, Betmiga works in a different way and is less likely to cause dry mouth or constipation. It is taken once daily and provides gradual, sustained symptom relief throughout the day thanks to its modified-release (MR) formulation.
This treatment is commonly prescribed either as a starting dose or for ongoing maintenance in patients who respond well to the medicine. Betmiga can improve bladder control and overall quality of life for people dealing with disruptive urinary symptoms.
It may take several weeks before full effects are noticeable, but many patients experience reduced urgency and frequency within the first month of treatment.
